| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2651 |
| Trial ID | NCT04836507 |
| Disease | Diffuse Large B-Cell Lymphoma | Primary Mediastinal B-Cell Lymphoma | Follicular Lymphoma | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CRC01 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients |
| Year | 2021 |
| Country | Korea,Republic of |
| Company sponsor | Curocell Inc. |
| Other ID(s) | CRC01-01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||